How the Branded Generics Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theBranded Generics Market?
The rising trend of chronic diseases is seen as a catalyst for the growth of the branded generics market. Chronic illnesses, often incurable but manageable, are seeing a surge due to factors such as increased tobacco use, malnutrition, lack of physical activity, and overconsumption of alcohol, among others. Globally, consumers prefer branded generics for dealing with chronic ailments, given their cost-effectiveness compared to regular medications. As an example, the World Health Organization’s (WHO) 2022 Highlights in September 2022 listed that out of the 41 million deaths worldwide, 74% were a result of noncommunicable diseases (NCDs) or chronic illnesses. Thus, the surge in incidents of chronic diseases is likely to stimulate the demand for branded generics in the coming years.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7186&type=smp
#What is the Anticipated CAGR of the Branded Generics Market, and What Factors Will Drive It?
In recent times, there has been a robust expansion in the size of the branded generics market. It is projected to rise from $363.49 billion in 2024 to $397.19 billion in 2025, registering a compound annual growth rate (CAGR) of 9.3%. Factors that have contributed to the growth during the historical period include affordability and cost savings, patent expiry dates, market proliferation and accessibility, governmental strategies and regulations, as well as healthcare overhauls.
Fast-paced expansion is projected for the branded generics market in the forthcoming years, with its size anticipated to reach $601.4 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.9%. Factors contributing to this growth during the forecast period include the escalating demand for generic biologics, the surge in chronic diseases, the expansion of emerging markets, and emphasis on biosimilars. Other key trends over the forecast period encompass strategic alliances and collaborations, advancements in technology, concentration on chronic diseases, market consolidation, and a patient-oriented approach.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7186
How Are Consumer Market Innovations Shaping the Current and Future Landscape of the Branded Generics Market?
Collaborative alliances are emerging as a significant trend in the branded generics marketplace. Companies within this sector are forming strategic collaborations with related businesses to effectively utilize each other’s resources and venture into unexplored markets. For instance, an illustrative example occurred in September 2024 when Biocon Ltd., a pharmaceutical company based in India, forged a partnership with Tabuk Pharmaceuticals. Biocon assumed the responsibility of the development and manufacture of GLP-1 products, focusing on creating superb quality biopharmaceuticals designed for diabetes care. Tabuk Pharmaceuticals acquired marketing authorization rights and assumed the responsibility for the registration, import, and promotion of the products throughout the Middle East, primarily in Saudi Arabia. The arrangement also considers potential expansion into other GLP products, widening the spectrum of diabetes care possibilities. This partnership aims to provide unique healthcare solutions for enhancing patient well-being in Saudi Arabia and nearby regions, in line with both companies’ devotion to boosting healthcare accessibility. Tabuk Pharmaceuticals, headquartered in Saudi Arabia, markets both branded and generic pharmaceutical products.
Who Are the Key Market Players Influencing the Growth of the Corn and Branded Generics Industry?
Major companies operating in the branded generics market include Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, AstraZeneca plc, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Mylan N.V., Sandoz International GmbH, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Aspen Pharmacare Holdings Limited, Endo International plc, Towa Pharmaceutical Co. Ltd., Mankind Pharma, Glenmark Pharmaceuticals, Par Pharmaceuticals Inc., Unichem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Wockhardt, Intas Pharmaceuticals Ltd., Novartis International AG, Novo Nordisk A/S, Zydus Lifesciences Ltd.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report
Which Key Market Segments Comprise the Branded Generics Market and Drive Its Revenue Growth?
The branded generics market covered in this report is segmented –
1) By Drug Class: Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Other Drugs
2) By Route Of Administration: Topical, Oral, Parenteral, Other Routes Of Administration
3) By Application: Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics And Anti-inflammatory, Other Applications
Subsegments:
1) By Alkylating Agents: Nitrogen Mustards, Ethylene Imine Compounds
2) By Antimetabolites: Purine Analogues, Pyrimidine Analogues
3) By Hormones: Corticosteroids, Thyroid Hormones
4) By Anti-Hypertensive: ACE Inhibitors, Beta Blockers, Calcium Channel Blockers
5) By Lipid Lowering Drugs: Statins, Fibrates
6) By Anti-Depressants: SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
7) By Anti-Psychotics: Atypical Antipsychotics, Typical Antipsychotics
8) By Anti-Epileptics: Sodium Channel Blockers, GABAergic Drugs
9) By Other Drugs: Analgesics, Antibiotics, Antivirals
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=7186&type=smp
Which Regions Are Emerging as Leaders in the Branded Generics Market?
North America was the largest region in the branded generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the branded generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Branded Generics Market 2025, By The Business Research Company:
Dairy Alternatives Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dairy-alternatives-global-market-report
Natural Food Colors And Flavors Global Market Report 2024
Functional Food Ingredients Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/functional-food-ingredients-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
